About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Signs a Multinational License for TPM® in Personal Care Products

December 4, 2017

Click here to read more

Post navigation

Phosphagenics Provides Update on TPM Propofol Development Program

Phosphagenics TPM Improves Negative Effects of Heat Stress in Poultry

Related Posts

Terumo Shifts Focus from Oxymorphone Patch to Injectables

March 20, 2018

Avecho Phase III insomnia trial advances following positive interim analysis

June 24, 2026June 24, 2026

Avecho reaches two-year stability milestone for its CBD softgel capsule

June 22, 2023June 22, 2023

Recent Posts

Euroz Hartleys | Successful Phase 3 Interim Results
July 8, 2026
Avecho Phase III insomnia trial advances following positive interim analysis
June 24, 2026
Euroz Hartleys Initiates Research Coverage
May 21, 2026

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.